NextCure Inc (NAS:NXTC)
$ 1.17 0 (0%) Market Cap: 32.77 Mil Enterprise Value: -37.15 Mil PE Ratio: 0 PB Ratio: 0.43 GF Score: 40/100

NextCure Inc at Bank of America Healthcare Conference Transcript

May 10, 2022 / 05:40PM GMT
Release Date Price: $3.38 (-0.88%)
Alec Warren Stranahan
BofA Securities, Research Division - Associate

Everyone, welcome to day 1 of the 2022 Bank of America Healthcare Conference, and thank you for joining this session with NextCure. My name is Alec Stranahan. I'm Vice President and senior biotech analysts covering NextCure at BofA. It's my pleasure to be joined by Michael Richman, President and CEO of NextCure. And I believe Michael is going to run through some slides upfront to get started, and then we'll go into Q&A after that.

So with that, Michael, over to you.

Michael S. Richman
NextCure, Inc. - Co-Founder, CEO, President & Director

Thank you very much, Alec, and it's a real pleasure to be here. I'd like to thank BofA for the opportunity to present NextCure.

NextCure is a company in Beltsville, Maryland. We're celebrating a little over 6 years at really building a fully-integrated organization focused on next-generation immunomedicines is our forward-looking statement.

I always like to start with this slide. This is our 3 Ps where really sets the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot